Dhrs3 - dehydrogenase/reductase 3 Gene
Species: Rattus norvegicus
Summary
Predicted to enable NAD-retinol dehydrogenase activity. Predicted to be involved in regulation of retinoic acid receptor signaling pathway and retinoid metabolic process. Predicted to act upstream of or within several processes, including animal organ morphogenesis; negative regulation of retinoic acid receptor signaling pathway; and regulation of ossification. Predicted to be integral component of membrane. Predicted to be active in lipid droplet. Orthologous to human DHRS3 (dehydrogenase/reductase 3). [provided by Alliance of Genome Resources, Apr 2022]
Dhrs3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001037199.3 | NP_001032276.3 | short-chain dehydrogenase/reductase 3 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
short-chain dehydrogenase/reductase 3 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS03741 | DHRS3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20392 | Dhrs3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26901 | Dhrs3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service